Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...
点击上方“Deephub Imba”,关注公众号,好文章不错过 !向量检索是整个RAG管道的一个重要的步骤,传统的暴力最近邻搜索因为计算成本太高,扩展性差等无法应对大规模的搜索。HNSW(Hierarchical Navigable Small ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果